Sign In
Buy MNKD
$3.36
-0.0700 (-2.04%)
At Close: Jun 03, 2026
MannKind Announces Ralinepag Dry Powder Inhalation (DPI) Program to be Pursued for Pulmonary Hypertension and Fibrotic Lung Diseases
06:30am, Wednesday, 06'th May 2026
The formulation is being developed in collaboration with United Therapeutics Corporation United Therapeutics made an additional $5 million payment to MannKind to support the rapid advancement of ral
MannKind to Report First Quarter 2026 Financial Results on May 6, 2026
04:01pm, Wednesday, 29'th Apr 2026
DANBURY, Conn. and WESTLAKE VILLAGE, Calif., April 29, 2026 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq: MNKD), a biopharmaceutical company dedicated to transforming chronic disease care through
MannKind Corporation (NASDAQ:MNKD) Short Interest Up 29.8% in March
03:20am, Thursday, 16'th Apr 2026
MannKind Corporation (NASDAQ: MNKD - Get Free Report) saw a large growth in short interest in March. As of March 31st, there was short interest totaling 29,464,200 shares, a growth of 29.8% from the M
MannKind (NASDAQ:MNKD) Shares Gap Up After Insider Buying Activity
01:58am, Thursday, 12'th Mar 2026
MannKind Corporation (NASDAQ: MNKD - Get Free Report) gapped up prior to trading on Wednesday after an insider bought additional shares in the company. The stock had previously closed at $2.61, but op
MannKind Corporation (MNKD) Presents at Barclays 28th Annual Global Healthcare Conference Transcript
03:32pm, Wednesday, 11'th Mar 2026
MannKind Corporation (MNKD) Presents at Barclays 28th Annual Global Healthcare Conference Transcript
MannKind to Present New Data From Pediatric and Adult Studies of Afrezza® at ATTD 2026
09:05am, Monday, 09'th Mar 2026
Presentations highlight real‑world dosing and titration patterns in youth, and post‑prandial glucose management strategies using inhaled insulin in both adults and youth with T1D Data to be featur
MannKind Announces Settlement of Convertible Senior Notes
04:30pm, Thursday, 05'th Mar 2026
DANBURY, Conn. and WESTLAKE VILLAGE, Calif., March 05, 2026 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq: MNKD) today announced the settlement of the remaining $36.3 million aggregate principal am
MannKind to Participate in Upcoming Investor Conferences
09:00am, Wednesday, 04'th Mar 2026
DANBURY, Conn. and WESTLAKE VILLAGE, Calif.
MannKind (NASDAQ:MNKD) Stock Price Down 6.6% on Analyst Downgrade
01:04am, Tuesday, 03'rd Mar 2026
MannKind Corporation (NASDAQ: MNKD - Get Free Report) traded down 6.6% during mid-day trading on Monday after Wall Street Zen downgraded the stock from a buy rating to a hold rating. The company trade
Why MannKind Stock Tumbled on Thursday
06:19pm, Thursday, 26'th Feb 2026
Investors weren't pleased with the biotech's bottom-line decline. It also missed the consensus analyst estimate for that metric.
MannKind Corporation (MNKD) Q4 2025 Earnings Call Transcript
04:57pm, Thursday, 26'th Feb 2026
MannKind Corporation (MNKD) Q4 2025 Earnings Call Transcript
Compared to Estimates, MannKind (MNKD) Q4 Earnings: A Look at Key Metrics
01:30pm, Thursday, 26'th Feb 2026
While the top- and bottom-line numbers for MannKind (MNKD) give a sense of how the business performed in the quarter ended December 2025, it could be worth looking at how some of its key metrics compa
MannKind (MNKD) Reports Q4 Loss, Tops Revenue Estimates
01:16pm, Thursday, 26'th Feb 2026
MannKind (MNKD) came out with a quarterly loss of $0.05 per share versus the Zacks Consensus Estimate of a loss of $0.01. This compares to earnings of $0.03 per share a year ago.
MannKind Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
08:00am, Thursday, 26'th Feb 2026
Q4 2025 revenues of $112M, +46% vs. Q4 2024 Furoscix ® Q4 2025 net sales of $23M, +91% vs.
MannKind to Participate in the Oppenheimer 36th Annual Healthcare Life Sciences Conference
09:00am, Thursday, 19'th Feb 2026
DANBURY, Conn. and WESTLAKE VILLAGE, Calif., Feb. 19, 2026 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq: MNKD), today announced Chief Executive Officer Michael Castagna, PharmD is scheduled to
